The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

It's been more than a year since the Food and Drug Administration approved the first vaccine to treat RSV. Since then, newly ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Vaccines for the Fall and Winter 2024–2025 season are now available. Generally, experts recommend COVID-19 and flu vaccines ...

The latest flu vaccines are now available, and just like the COVID-19 shots, it's recommended to get the flu shot in ...

When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here's what ...

Nursing homes in New York are being urged to protect residents with the updated COVID-19 vaccine. The NYS Department of ...

There isn’t a combination vaccine available so far but it might not be too far off — Moderna recently said it plans to file ...

During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year.

This summary covers various health news: a Nipah virus death in Kerala, Gaza's polio vaccination coverage success, brain ...

Respiratory virus season is fast approaching, which means an uptick in flu, COVID-19 and RSV cases. But there are vaccines that can protect you against all three of these diseases, including a new ...

Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key ...